Bio-Techne
TECH
$83.50
Share price
1.45%
Change (1 day)
-13.60%
Change (1 year)
Categories
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.
P/S ratio for Bio-Techne (TECH)
P/S ratio as of May 2023 (TTM): 11.7
According to Bio-Techne's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.7159. At the end of 2023 the company had a P/S ratio of 10.4.
P/S ratio history for Bio-Techne from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 10.4 | -10.06% |
| 2022 | 11.6 | -41.16% |
| 2021 | 19.7 | 28.67% |
| 2020 | 15.3 | 35.99% |
| 2019 | 11.3 | 40.86% |
| 2018 | 8.01 | -1.07% |
| 2017 | 8.10 | 11.46% |
| 2016 | 7.26 | 0.94% |
| 2015 | 7.20 | -14.26% |
| 2014 | 8.39 | -20.67% |
| 2013 | 10.6 | 31.29% |
| 2012 | 8.06 | -2.18% |
| 2011 | 8.24 | -7.85% |
| 2010 | 8.94 | -7.32% |
| 2009 | 9.65 | 7.08% |
| 2008 | 9.01 | -16.95% |
| 2007 | 10.8 | 5.15% |
| 2006 | 10.3 | -9.54% |
| 2005 | 11.4 | 19.31% |
| 2004 | 9.56 | -5.57% |
| 2003 | 10.1 | 17.54% |
| 2002 | 8.61 | -31.35% |
| 2001 | 12.5 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 4.60 | -60.78% | 🇺🇸 USA |
 Becton Dickinson BDX | 3.64 | -68.89% | 🇺🇸 USA |
 General Electric GE | 1.62 | -86.15% | 🇺🇸 USA |
 Danaher DHR | 5.54 | -52.74% | 🇺🇸 USA |
 Qiagen QGEN | 5.26 | -55.09% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | 1.41 | -87.97% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | 4.04 | -65.52% | 🇺🇸 USA |